Ligand profile
N1T
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04322 — putative transketolase family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
N1T- PDB
1tkb- UniProt (similar protein)
P23254- Target protein
- KP13_04322
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 158.9
- −1 ≤ LogP ≤ 5 0.81
- MW ≤ 500 Da 423.3
- LogP ≤ 5 0.81
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 158.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccc(c(n1)N)C[n+]2csc(c2C)CCO[P@](=O)(O)O[P@@](=O)(O)[O-]Cc1ccc(c(n1)N)C[n+]2csc(c2C)CCO[P@](=O)(O)O[P@@](=O)(O)[O-]
InChI=1S/C13H19N3O7P2S/c1-9-3-4-11(13(14)15-9)7-16-8-26-12(10(16)2)5-6-22-25(20,21)23-24(17,18)19/h3-4,8H,5-7H2,1-2H3,(H4-,14,15,17,18,19,20,21)InChI=1S/C13H19N3O7P2S/c1-9-3-4-11(13(14)15-9)7-16-8-26-12(10(16)2)5-6-22-25(20,21)23-24(17,18)19/h3-4,8H,5-7H2,1-2H3,(H4-,14,15,17,18,19,20,21)
JHNXLHRDUXBCJW-UHFFFAOYSA-NJHNXLHRDUXBCJW-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00456' 'PF02779
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand N1T →
- PDB RCSB structure 1tkb →
- UniProt UniProt P23254 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “N1T”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04322.
PDB 12
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 30
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).